Compare A O Smith Corp (AOS) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
A O Smith Corp vs Tenet Healthcare Corporation — how do they compare? A O Smith Corp trades at $62.75 (market cap $8.65B), while Tenet Healthcare Corporation trades at $267.65 (market cap $20.89B). The key difference: Tenet Healthcare Corporation is far larger — about 2.4× A O Smith Corp's market cap, and A O Smith Corp pays a 2.26% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| AOS | THC | |
|---|---|---|
Market Cap | $8.65B | $20.89B |
Sector | Industrials | Health |
52-Week High | $80.47 | $262.63 |
52-Week Low | $55.78 | $161.37 |
Enterprise Value | $9.15B | $31.97B |
Dividend Yield | 2.26% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
A. O. Smith Corporation (AOS) trades at $62.47, showing modest daily gains. The stock exhibits a bullish technical trend with strong moving average signals, though RSI levels suggest potential near-term overbought conditions. Fundamentally, the company maintains solid profitability with a net income margin of 13.15% and ROE of 27.13%, supported by consistent revenue around $3.8 billion. Recent Q2 2026 earnings beat expectations, but Q1 2026 was a miss, reflecting some volatility. A quarterly dividend of $0.36 provides income appeal.
The outlook for AOS is cautiously optimistic, with a consensus price target of $67.25 implying upside potential. Strengths include robust cash flow from operations and high return metrics. Key risks involve exposure to input cost pressures, competitive markets, and mixed quarterly earnings performance. Investor sentiment is balanced, with analyst ratings leaning Hold. The stock presents a value opportunity for those comfortable with industrial sector cyclicality.
Tenet Healthcare (THC) trades at $266.15, up 2.39% today, with strong technical momentum including a golden cross formation. The stock shows robust fundamentals with a P/E of 10.03, net income margin of 9.9%, and consistent earnings beats in recent quarters. Recent Q2 2026 results exceeded expectations with EPS of $6.12 versus $4.26 estimate, driving positive analyst sentiment.
Outlook remains positive with 81% analyst buy ratings and $281.44 consensus price target, though investors should monitor policy headwinds in healthcare and the stock's proximity to 52-week highs. The company's ambulatory growth and raised 2026 guidance support continued upside potential despite net cash flow challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About A O Smith Corp
A.O. Smith Corporation manufactures and markets comprehensive lines of residential and commercial gas, gas tankless, and electric water heaters. Supplementary products include water heating equipment, condensing and noncondensing boilers, and water system tanks. The company's two operating segments are by geographic region: North America (majority of total revenue) and the Rest of the World. A material portion of sales in North America derive from replacing existing products, and the company utilizes a wholesale distribution channel and multiple selling locations. The Rest of the World segment sells primarily to Asian countries and operates sales offices to expand distribution and market its product portfolio.
Read more on AOS →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
